Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05761561 · ClinicalTrials.gov registry record · NA
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
A NA study of Ovarian Cancer, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT05761561 is a NA study of Ovarian Cancer that is actively recruiting participants, run by Yale University. The registered enrollment target is 200 participants, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05761561, a NA study of Ovarian Cancer, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
An anticipated 200 women with newly diagnosed ovarian and endometrial cancer scheduled to receive chemotherapy (adjuvant chemotherapy after surgery or neoadjuvant chemotherapy before surgery) will be recruited from Smilow Cancer Hospital Network at Yale Cancer Center (YCC) and Sylvester Comprehensive Cancer Center (SCCC) at University of Miami. Participants will be randomized to an exercise and medical nutrition intervention arm with weekly counseling sessions throughout chemotherapy, or a control arm. Study assessments will be conducted at baseline, post-chemotherapy/end of intervention and at 1-year post diagnosis. Women who are prescribed neoadjuvant therapy will have additional assessments prior to surgery. Data required to calculate the primary endpoint (relative dose intensity of chemotherapy) will be abstracted from the medical record directly following each chemotherapy session.
Conditions Studied
Interventions
- BEHAVIORAL Exercise and medical nutrition
Study Locations (2)
Connecticut
- Yale University - New Haven
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-04-19 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05761561
The ClinicalTrials.gov registry entry for NCT05761561 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (73% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise and medical nutrition is the first listed.
NCT05761561 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT05761561 about?
NCT05761561 is a clinical study titled "Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer". An anticipated 200 women with newly diagnosed ovarian and endometrial cancer scheduled to receive chemotherapy (adjuvant chemotherapy after surgery or neoadjuvant chemotherapy before surgery) will be recruited from Smilow Cancer Hospital Network at Yale Cancer Center (YCC) and Sylvester Comprehensiv...
What is the current status of trial NCT05761561?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-04-19. Estimated completion is 2027-06.
What conditions does trial NCT05761561 study?
This clinical trial studies the following conditions: Ovarian Cancer.
What interventions are being tested in trial NCT05761561?
The interventions under investigation include: Exercise and medical nutrition (BEHAVIORAL).
Who is sponsoring clinical trial NCT05761561?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05761561 being conducted?
This trial has 2 study locations across Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.